Key result
This letter emphasizes the importance of considering patient-centered outcomes, such as cognitive function, in clinical trials evaluating atrial fibrillation catheter ablation.
Answers are grounded in this paper and cite their sources.
This letter emphasizes the importance of considering patient-centered outcomes, such as cognitive function, as endpoints in clinical trials for atrial fibrillation ablation.
HomeCirculation: Arrhythmia and ElectrophysiologyVol. 12, No. 10Letter by Sepehri Shamloo et al Regarding Article, "Atrial Fibrillation Catheter Ablation Improves 1-Year Follow-Up Cognitive Function, Especially in Patients with Impaired Cognitive Function" Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBLetter by Sepehri Shamloo et al Regarding Article, "Atrial Fibrillation Catheter Ablation Improves 1-Year Follow-Up Cognitive Function, Especially in Patients with Impaired Cognitive Function" Alireza Sepehri Shamloo, MD, Nikolaos Dagres, MD and Gerhard Hindricks, MD Alireza Sepehri ShamlooAlireza Sepehri Shamloo Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig Heart Institute, Leipzig, Germany. , Nikolaos DagresNikolaos Dagres Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig Heart Institute, Leipzig, Germany. and Gerhard HindricksGerhard Hindricks Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig Heart Institute, Leipzig, Germany. Originally published10 Oct 2019https://doi.org/10.1161/CIRCEP.119.007822Circulation: Arrhythmia and Electrophysiology. 2019;12:e007822To the Editor:The term cognitive function in the context of cardiac arrhythmias was first introduced 30 years ago when evidence of cognitive impairment was reported in patients with chronic atrial fibrillation (AF). During the last decades, the topic of cognitive function assessment in AF patients has emerged as a hot topic in the field of electrophysiology; >50 studies have investigated the relationship between these 2 significant public health concerns so far.1The recently published study conducted by Jin et al2 is groundbreaking and not only confirms findings previously reported by Bunch et al3 about the positive impact of AF ablation on cognitive function but also emphasizes the importance of considering patient-centered outcomes as end points in clinical trials. During the last few decades, hundreds of studies in the field of cardiac arrhythmias have investigated the impact of different therapeutic strategies on major clinical variables including bleeding, stroke, arrhythmia recurrence, and mortality; and a number of them have covered the psychocognitive status as main outcomes. We think that the findings of this current study call to attention the importance of including patient-centered outcomes and also patient-reported outcomes as end points in clinical trials.Currently, management of cognitive dysfunction and controlling the global burden of dementia is one of the top public health priorities designated by the World Health Organization. Moreover, we should not forget that the adherence of treatment and medication intake might be adversely affected by cognitive dysfunction, thereby negatively influencing outcomes and therapy efficiency in the patients suffering from arrhythmias.1 Although more investigations are required to better define the impact of AF ablation on cognitive status, the recent findings of Jin et al, in conjunction with other studies might be an indication that ablation can improve depression and cognitive function.3–5 This, if supported by further studies, might ultimately lead to the question whether it is time to consider psychocognitive impairments as new indications for AF catheter ablation.Although the current study by Jin et al helps us complete the puzzle of the association between AF, the most common cardiac arrhythmia, and cognitive function, the question which arrhythmia is associated with a greater impairment of cognitive function is still unanswered. Moreover, there is a still a lack of evidence about the impact of different arrhythmia-related procedures, including medical treatment, cardiac device implantation, ablation, or others on patients' cognitive function. So, when we face this question: Do we need further studies in this field?; the answer is definitely yes. More specifically, the 2 main topics that in our opinion need to be addressed more intensively are (1) the epidemiological understanding of the association between arrhythmias and cognitive function and (2) the impact of arrhythmia-related therapies on cognitive function.DisclosuresDrs Dagres and Hindricks report research grants from Abbott and Boston Scientific to the institution without personal financial benefits. Dr Sepehri Shamloo does not declare any conflict of interest.References1. Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK; ESC Scientific Document Group. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?Europace. 2018; 20:1399–1421. doi: 10.1093/europace/euy046CrossrefMedlineGoogle Scholar2. Jin MN, Kim TH, Kang KW, Yu HT, Uhm JS, Joung B, Lee MH, Kim E, Pak HN. Atrial fibrillation catheter ablation improves 1-year follow-up cognitive function, especially in patients with impaired cognitive function.Circ Arrhythm Electrophysiol. 2019; 12:e007197. doi: 10.1161/CIRCEP.119.007197LinkGoogle Scholar3. Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day JD. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation.J Cardiovasc Electrophysiol. 2011; 22:839–845. doi: 10.1111/j.1540-8167.2011.02035.xCrossrefMedlineGoogle Scholar4. Thrall G, Lip GY, Carroll D, Lane D. Depression, anxiety, and quality of life in patients with atrial fibrillation.Chest. 2007; 132:1259–1264. doi: 10.1378/chest.07-0036CrossrefMedlineGoogle Scholar5. Walters TE, Wick K, Tan G, Mearns M, Joseph SA, Morton JB, Sanders P, Bryant C, Kistler PM, Kalman JM. Psychological distress and suicidal ideation in patients with atrial fibrillation: prevalence and response to management strategy.J Am Heart Assoc. 2018; 7:e005502. doi: 10.1161/JAHA.117.005502LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails October 2019Vol 12, Issue 10 Advertisement Article InformationMetrics © 2019 American Heart Association, Inc.https://doi.org/10.1161/CIRCEP.119.007822PMID: 31597474 Originally publishedOctober 10, 2019 PDF download Advertisement SubjectsArrhythmiasAtrial FibrillationMental HealthQuality and OutcomesRisk Factors
No takes yet. Share an insight, caveat, or question.
Shamloo et al. (2019) conducted a letter in Atrial Fibrillation. Atrial fibrillation catheter ablation was evaluated on Cognitive function. This letter emphasizes the importance of considering patient-centered outcomes, such as cognitive function, in clinical trials evaluating atrial fibrillation catheter ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: